Datum objave: 10.02.2017. 09:57

(MK) Nabavka lijekova

Former Yugoslav Republic of Macedonia-Skopje: Injectable solutions

2017/S 029-053230

Contract notice

Supplies

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

University Clinic of Cardiology
Vodnjanska 17, Meri Mandalova
Contact point(s): +389 2 3147181, +389 2 3164134
For the attention of: https://e-nabavki.gov.mk/
1000 Skopje
The former Yugoslav Republic of Macedonia
Telephone: +389 023147576
E-mail: kardiologijaskopje@gmail.com
Fax: +389 023211662

Internet address(es):

General address of the contracting authority: https://e-nabavki.gov.mk/

Further information can be obtained from: The above mentioned contact point(s)

Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)

Tenders or requests to participate must be sent to: The above mentioned contact point(s)

I.2)Type of the contracting authority

Other: university hospital
 

I.3)Main activity

Health
 

I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: no
 

Section II: Object of the contract

II.1)Description

II.1.1)Title attributed to the contract by the contracting authority:

Medicines — covered by the HIFM, Medicines — not covered by HIFM and MEDICINES not registered in Republic of Macedonia.
 

II.1.2)Type of contract and location of works, place of delivery or of performance

Supplies
Main site or location of works, place of delivery or of performance: PHI Clinic of Cardiology.
NUTS code 
 

II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)

II.1.4)Information on framework agreement

II.1.5)Short description of the contract or purchase(s)

Medicines — covered by the HIFM, Medicines — not covered by HIFM and MEDICINES not registered in Republic of Macedonia.
 

II.1.6)Common procurement vocabulary (CPV)

33692500

II.1.7)Information about Government Procurement Agreement (GPA)

II.1.8)Lots

This contract is divided into lots: yes
Tenders may be submitted for one or more lots
 

II.1.9)Information about variants

II.2)Quantity or scope of the contract

II.2.1)Total quantity or scope:

II.2.2)Information about options

II.2.3)Information about renewals

II.3)Duration of the contract or time limit for completion

Information about lots

Lot No: 1 Lot title: R03DA05 AMINOPHYLLINE 350mg tablet with extended release piece

1)Short description

R03DA05 AMINOPHYLLINE 350mg tablet with extended release piece.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 2 Lot title: J01FA09 CLARITHROMYCIN 500mg film-coated tablet/modified-release tablet

1)Short description

J01FA09 CLARITHROMYCIN 500mg film-coated tablet/modified-release tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 3 Lot title: C01AA05 DIGOXIN 0.25mg tablet

1)Short description

C01AA05 DIGOXIN 0.25mg tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 4 Lot title: B03AB05 DEXTRIFERRON 100mg tablet

1)Short description

B03AB05 DEXTRIFERRON 100mg tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 5 Lot title: B02BX02 CARBAZOCHROME 25mg tablet

1)Short description

B02BX02 CARBAZOCHROME 25mg tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 6 Lot title: C03CA01 FUROSEMIDE 40mg tablet

1)Short description

C03CA01 FUROSEMIDE 40mg tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 7 Lot title: C03CA01 FURSEMIDE 500mg tablet

1)Short description

C03CA01 FURSEMIDE 500mg tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 8 Lot title: A02BA03 FAMOTIDINE 20mg film-coated tablet

1)Short description

A02BA03 FAMOTIDINE 20mg film-coated tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 9 Lot title: C08CA13 LERCANIDIPINE 10mg film-coated tablet

1)Short description

C08CA13 LERCANIDIPINE 10mg film-coated tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 10 Lot title: A10BA02 METFORMIN 1000mg film-coated tablet

1)Short description

A10BA02 METFORMIN 1000mg film-coated tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 11 Lot title: J01MA06 NORFLOXACIN 400mg film-coated tablet

1)Short description

J01MA06 NORFLOXACIN 400mg film-coated tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 12 Lot title: C08CA05 NIFEDIPINE 40mg modified-release tablet

1)Short description

C08CA05 NIFEDIPINE 40mg modified-release tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 13 Lot title: A07AX03 NIFUROXAZIDE 200mg capsule, hard-shelled capsule

1)Short description

A07AX03 NIFUROXAZIDE 200mg capsule, hard-shelled capsule.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 14 Lot title: C09AA04 PERINDOPRIL 4mg tablet

1)Short description

C09AA04 PERINDOPRIL 4mg tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 15 Lot title: A12BA01 POTASSIUM CHLORIDE 0.5gr tablet for oral solution

1)Short description

A12BA01 POTASSIUM CHLORIDE 0.5gr tablet for oral solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 16 Lot title: B01AF01 RIVAROXABAN 20 mg film-coated tablet

1)Short description

B01AF01 RIVAROXABAN 20 mg film-coated tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 17 Lot title: C03CA04 TORASEMIDE 10mg tablet

1)Short description

C03CA04 TORASEMIDE 10mg tablet.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 18 Lot title: B01AC13 ABCIXIMAB 2mg/ml injection solution or infusion

1)Short description

B01AC13 ABCIXIMAB 2mg/ml injection solution or infusion.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 19 Lot title: B05AA01 HUMAN ALBUMIN 200g/L, 20 %, 200mg/1ML, 0.2g/1ml, 20g/100ml infusion solution

1)Short description

B05AA01 HUMAN ALBUMIN 200g/L, 20 %, 200mg/1ML, 0.2g/1ml, 20g/100ml infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 20 Lot title: C01EB10 ADENOZINE 3mg/ml injection solution piece

1)Short description

C01EB10 ADENOZINE 3mg/ml injection solution piece.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 21 Lot title: C01BD01 AMIODARONE 150mg/3ml injection solution, injection solution or infusion-

1)Short description

C01BD01 AMIODARONE 150mg/3ml injection solution, injection solution or infusion-.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 22 Lot title: R03DA05 AMINOPHYLLINE 250mg/10ml injection solution

1)Short description

R03DA05 AMINOPHYLLINE 250mg/10ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 23 Lot title: B01AD02 ALTEPLASE 50mg powder and solvent for injection solution/infusion -piece — vial

1)Short description

B01AD02 ALTEPLASE 50mg powder and solvent for injection solution/infusion -piece — vial.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 24 Lot title: J01DD04 CEFTRIAXONE 1000mg(1g) powder for injection solution/powder and solvent for injection solution -piece- vial/vial

1)Short description

J01DD04 CEFTRIAXONE 1000mg(1g) powder for injection solution/powder and solvent for injection solution -piece- vial/vial.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 25 Lot title: J01FF01 CLINDAMYCIN 600mg/4ml injection solution, injection solution or infusion

1)Short description

J01FF01 CLINDAMYCIN 600mg/4ml injection solution, injection solution or infusion.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 26 Lot title: J01MA02 CIPROFLOXACIN 100mg/10ml concentrate for infusion solution

1)Short description

J01MA02 CIPROFLOXACIN 100mg/10ml concentrate for infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 27 Lot title: R06AC03 CHLOROPYRAMINE 20mg/2ml injection solution

1)Short description

R06AC03 CHLOROPYRAMINE 20mg/2ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 28 Lot title: H02AB02 DEXAMETHASONЕ 4mg/1ml injection solution

1)Short description

H02AB02 DEXAMETHASONЕ 4mg/1ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 29 Lot title: N05BA01 DIAZEPAM 5mg/1ml(10мg/2ml) injection solution, injection solution or infusion

1)Short description

N05BA01 DIAZEPAM 5mg/1ml(10мg/2ml) injection solution, injection solution or infusion.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 30 Lot title: C01CA07 DOBUTAMINE 250mg/20ml concentrate for infusion solution

1)Short description

C01CA07 DOBUTAMINE 250mg/20ml concentrate for infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 31 Lot title: B02BX02 CARBAZOCHROME 10mg/2ml injection solution

1)Short description

B02BX02 CARBAZOCHROME 10mg/2ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 32 Lot title: C09AA02 ENALAPRILAT 1.25mg/1ml injection solution

1)Short description

C09AA02 ENALAPRILAT 1.25mg/1ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 33 Lot title: C01CA24 EPINEPHRINE 1mg/1ml injection solution

1)Short description

C01CA24 EPINEPHRINE 1mg/1ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 34 Lot title: B01AB05 ENOXAPARIN 2000 anti- XA IE/0.2ml injection solution

1)Short description

B01AB05 ENOXAPARIN 2000 anti- XA IE/0.2ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 35 Lot title: B01AB05 ENOXAPARIN 4000 anti- XA IE/0.4ml injection solution

1)Short description

B01AB05 ENOXAPARIN 4000 anti- XA IE/0.4ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 36 Lot title: J02AC01 FLUCONAZOLE 2mg/1ml — infusion solution

1)Short description

J02AC01 FLUCONAZOLE 2mg/1ml — infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 37 Lot title: C01BC04 FLECAINIDE 10mg/ml injection solution

1)Short description

C01BC04 FLECAINIDE 10mg/ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 38 Lot title: C03CA01 FUROSEMIDE 20mg/2ml injection solution

1)Short description

C03CA01 FUROSEMIDE 20mg/2ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 39 Lot title: V03AB25 FLUMAZENIL 5ml/0.5mg injection solution

1)Short description

V03AB25 FLUMAZENIL 5ml/0.5mg injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 40 Lot title: C01DA02 GLYCERYL TRINITRATE 5mg/1.6ml concentrate for infusion solution

1)Short description

C01DA02 GLYCERYL TRINITRATE 5mg/1.6ml concentrate for infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 41 Lot title: B01AB01 HEPARIN 25000IE/5ml injection solution

1)Short description

B01AB01 HEPARIN 25000IE/5ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 42 Lot title: A10AB05 INSULIN aspart 100 IE/1ml injection solution

1)Short description

A10AB05 INSULIN aspart 100 IE/1ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 43 Lot title: A10AC01 INSULIN( HUMAN) 100 IE/1ml injection suspension

1)Short description

A10AC01 INSULIN( HUMAN) 100 IE/1ml injection suspension.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 44 Lot title: N05AA02 LEVOMEPROMAZINE 25mg/1ml injection solution/infusion solution

1)Short description

N05AA02 LEVOMEPROMAZINE 25mg/1ml injection solution/infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 45 Lot title: A03FA01 METOCLOPRAMIDE 10mg/2ml injection solution

1)Short description

A03FA01 METOCLOPRAMIDE 10mg/2ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 46 Lot title: H02AB04 METHYLPREDNISOLONE/METHYLPREDNISOLONE SUCCINATE NATRIUM

1)Short description

H02AB04 METHYLPREDNISOLONE/METHYLPREDNISOLONE SUCCINATE NATRIUM
40mg(40mg/1ml) injection suspension/powder and solvent for injection solution/powder and solvent for injection solution or infusion.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 47 Lot title: N02AA01 MORPHINE 20mg/1ml injection solution

1)Short description

N02AA01 MORPHINE 20mg/1ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 48 Lot title: N05CD08 MIDAZOLAM 5mg/5ml injection solution

1)Short description

N05CD08 MIDAZOLAM 5mg/5ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 49 Lot title: V03AB15 NALOXONE 0.4mg/ml injection solution or infusion

1)Short description

V03AB15 NALOXONE 0.4mg/ml injection solution or infusion.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 50 Lot title: A02BC02 PANTOPRAZOLE 40mg powder for injection solution, powder for injection solution or infusion

1)Short description

A02BC02 PANTOPRAZOLE 40mg powder for injection solution, powder for injection solution or infusion.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 51 Lot title: J01MA03 PEFLOXACIN 400mg/5ml injection solution

1)Short description

J01MA03 PEFLOXACIN 400mg/5ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 52 Lot title: N01AX10 PROPOFOL 10mg/1ml injection emulsion or infusion

1)Short description

N01AX10 PROPOFOL 10mg/1ml injection emulsion or infusion.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 53 Lot title: B02BA01 PHYTOMENADIONE 10mg/ml injection solution

1)Short description

B02BA01 PHYTOMENADIONE 10mg/ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 54 Lot title: B05XA02 SODIUM BICARBONATE 8.4 % -injection solution

1)Short description

B05XA02 SODIUM BICARBONATE 8.4 % -injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 55 Lot title: B01AC17 TIROFIBAN 0.25mg/1ml -concentrate for infusion solution

1)Short description

B01AC17 TIROFIBAN 0.25mg/1ml -concentrate for infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 56 Lot title: N02AX02 TRAMADOL 50mg/1ml injection solution

1)Short description

N02AX02 TRAMADOL 50mg/1ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 57 Lot title: C02CA06 URAPIDIL 25mg/5ml injection solution

1)Short description

C02CA06 URAPIDIL 25mg/5ml injection solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 58 Lot title: J01XA01 VANCOMYCIN 1000mg(1gr) powder for infusion solution, powder for concentrate for infusion solution, powder for infusion solution or for oral solution

1)Short description

J01XA01 VANCOMYCIN 1000mg(1gr) powder for infusion solution, powder for concentrate for infusion solution, powder for infusion solution or for oral solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 59 Lot title: M01AB05 DICLOFENAC 50mg suppository

1)Short description

M01AB05 DICLOFENAC 50mg suppository.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 60 Lot title: B05BA03 carbohydrates/glucose (solutions for parenteral nutrition) 5 % infusion solution

1)Short description

B05BA03 carbohydrates/glucose (solutions for parenteral nutrition) 5 % infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 61 Lot title: B05BB01 ELECTROLYTES 1 % 1000 ml solution should contain: sodium chloride. . . 8,60 g potassium chloride. . . 0,30 g calcium chloride dihydrate. . . 0,33 g (equivalent to 0,249 g calcium chloride infusion solution- ml- LDPE bottle PE bottle maximum 500 ml

1)Short description

B05BB01 ELECTROLYTES 1 % 1000 ml solution should contain: sodium chloride. . . 8,60 g potassium chloride. . . 0,30 g calcium chloride dihydrate. . . 0,33 g (equivalent to 0,249 g calcium chloride infusion solution- ml- LDPE bottle PE bottle maximum 500 ml.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 62 Lot title: B05XA03/B05BB01 SODIUM CHLORIDE, ELECTROLYTES 0,9 % infusion solution

1)Short description

B05XA03/B05BB01 SODIUM CHLORIDE, ELECTROLYTES 0,9 % infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 63 Lot title: B05XA03/B05BB01 ELECTROLYTES, SODIUM CHLORIDE 0,9 % infusion solution

1)Short description

B05XA03/B05BB01 ELECTROLYTES, SODIUM CHLORIDE 0,9 % infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Lot No: 64 Lot title: B05BC01 MANNITOL 20 %(200mg/1ml) infusion solution

1)Short description

B05BC01 MANNITOL 20 %(200mg/1ml) infusion solution.
 

2)Common procurement vocabulary (CPV)

33692500

3)Quantity or scope

4)Indication about different date for duration of contract or starting/completion

5)Additional information about lots

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract

III.1.1)Deposits and guarantees required:

Offer guarantee: Yes [3.00 %].
 

III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:

III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:

III.1.4)Other particular conditions

III.2)Conditions for participation

III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers

Information and formalities necessary for evaluating if the requirements are met: For personal condition confirmation, economic operator should submit these documents:
— Statement of economic operator that in the last five years there was no effective conviction for participation in criminal organization, corruption, fraud or money laundering.
— Certificate that any competent authority has initiated no open bankruptcy procedure.
— Certificate that any competent authority has initiated no open liquidation procedure.
— Certificate for paid taxes, contributions and other public payments by competent authority in the country where the economic operator has been registered in.
— Certificate from the Register of penalties for crimes committed by legal persons that there is no minor penalty that prohibits participation in procedures for public announcement, awarding contracts on public procurements and contract for public-private partnership
— Certificate from Register of penalties for crimes committed by legal persons that there is no effective conviction for temporary or permanent prohibition to perform certain activity
— Certificate that there is no effective conviction by which infringement sanction has been imposed on — interdiction for professional activities, activities or duties, i.e. temporary interdiction of separate activity realization.
 

III.2.2)Economic and financial ability

III.2.3)Technical capacity

Information and formalities necessary for evaluating if the requirements are met:
Document of Registered Activity — DRA Form or certificate of registered activity — Medicine Wholesale Decision pursuant to the Law on Medicines and Medical Devices
Documents necessary for proving the technical and the professional capability of the economic operator:
For the registered medical devices — Decision on Marketing of Finished Medicine or permanent approval for parallel import, pursuant to the Law on Medicines and Medical Devices. For not registered medical devices — Import Permission (interventional import approval) pursuant to the Law on Medicines and Medical Devices.
Minimum criteria to determine the economic and financial standing of economic operator:
For the registered medical devices — Decision on Marketing of Finished Medicine or permanent approval for parallel import, pursuant to the Law on Medicines and Medical Devices. For not registered medical devices — Import Permission (interventional import approval) pursuant to the Law on Medicines and Medical Devices.
 

III.2.4)Information about reserved contracts

III.3)Conditions specific to services contracts

III.3.1)Information about a particular profession

III.3.2)Staff responsible for the execution of the service

Section IV: Procedure

IV.1)Type of procedure

IV.1.1)Type of procedure

Open
 

IV.1.2)Limitations on the number of operators who will be invited to tender or to participate

IV.1.3)Reduction of the number of operators during the negotiation or dialogue

IV.2)Award criteria

IV.2.1)Award criteria

Lowest price
 

IV.2.2)Information about electronic auction

An electronic auction will be used: yes
Additional information about electronic auction: At the abovementioned address.
 

IV.3)Administrative information

IV.3.1)File reference number attributed by the contracting authority:

IV.3.2)Previous publication(s) concerning the same contract

IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document

IV.3.4)Time limit for receipt of tenders or requests to participate

28.3.2017 - 13:00
 

IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates

IV.3.6)Language(s) in which tenders or requests to participate may be drawn up

Any EU official language
Other: Macedonian.
 

IV.3.7)Minimum time frame during which the tenderer must maintain the tender

IV.3.8)Conditions for opening of tenders

Section VI: Complementary information

VI.1)Information about recurrence

VI.2)Information about European Union funds

VI.3)Additional information

VI.4)Procedures for appeal

VI.4.1)Body responsible for appeal procedures

VI.4.2)Lodging of appeals

VI.4.3)Service from which information about the lodging of appeals may be obtained

VI.5)Date of dispatch of this notice:

9.2.2017